Strong Immune Responses and Robust Protection Following a Novel Protein in Adjuvant Tuberculosis Vaccine Candidate

Researchers evaluated the immunogenicity and efficacy of the promising mycobacterial antigen PPE15, formulated with five adjuvants developed by the Vaccine Formulation Institute.